Tumors of the mouse hematopoietic system: their diagnosis and interpretation in safety evaluation tests. Report of a study group - PubMed
Review
Tumors of the mouse hematopoietic system: their diagnosis and interpretation in safety evaluation tests. Report of a study group
G N Wogan. Crit Rev Toxicol. 1984.
Abstract
A nomenclature for tumors of the mouse hematopoietic system is proposed. This nomenclature, which will be particularly appropriate for use in safety assessment studies, employs basic cytologic terminology, and subclassifications may take into consideration tissue sites and the presence or absence of leukemia. Analysis of tumor incidence in any given study can take into account the consolidation or separation of various tumor types as pathological and biological judgment indicates. The proposed system should be easily understood by pathologists and can be related to other species. Safety assessments of substances that induce tumors of the murine hematopoietic tumors are complicated by difficulty in diagnosis, by the possible involvement of oncogenic viruses, and by other factors such as genetics, immune status, endocrine status, and diet. These various influences are evaluated in respect to interpretation of safety evaluation data.
Similar articles
-
Lymphomas and leukemias in mice.
Ward JM. Ward JM. Exp Toxicol Pathol. 2006 Jul;57(5-6):377-81. doi: 10.1016/j.etp.2006.01.007. Epub 2006 May 18. Exp Toxicol Pathol. 2006. PMID: 16713211
-
Modulation of the incidence of murine leukemia and lymphoma.
Clayson DB. Clayson DB. Crit Rev Toxicol. 1984;13(2):183-95. doi: 10.3109/10408448409034081. Crit Rev Toxicol. 1984. PMID: 6380961 Review. No abstract available.
-
EFSA GMO Panel Working Group on Animal Feeding Trials. EFSA GMO Panel Working Group on Animal Feeding Trials. Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Food Chem Toxicol. 2008. PMID: 18328408 Review.
-
Studies on leukemia development in the SJL/J strain of mice.
Haran-Ghera N, Kotler M, Meshorer A. Haran-Ghera N, et al. J Natl Cancer Inst. 1967 Oct;39(4):653-61. J Natl Cancer Inst. 1967. PMID: 18623927
Cited by
-
Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse.
Turton JA, Sones WR, Andrews CM, Pilling AM, Williams TC, Molyneux G, Rizzo S, Gordon-Smith EC, Gibson FM. Turton JA, et al. Int J Exp Pathol. 2006 Feb;87(1):49-63. doi: 10.1111/j.0959-9673.2006.00455.x. Int J Exp Pathol. 2006. PMID: 16436113 Free PMC article.
-
Iversen OH. Iversen OH. Br J Ind Med. 1989 Sep;46(9):608-16. doi: 10.1136/oem.46.9.608. Br J Ind Med. 1989. PMID: 2506921 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical